Smoking p66Shc Knocked Out Mice Develop Respiratory Bronchiolitis with Fibrosis but Not Emphysema
Open Access
- 19 March 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (3) , e0119797
Abstract
The adaptor protein p66Shc regulates intracellular oxidant levels through the modulation of a forkhead-related transcription factor (FOXO3a). The genetic ablation of p66Shc (p66Shc–/–) renders mice resistant to oxidative stress and p53-dependent apoptosis. We investigated whether p66Shc ablation in mice modifies lung cellular and molecular responses to cigarette smoke (CS) exposure. No differences between wild type (WT) and p66Shc–/– mice were observed in terms of inflammation and oxidant burden after acute CS exposure; however,p66Shc ablation modifies specific features of chronic inflammation induced by repeated exposure to CS. Unlike WT mice, p66Shc–/– mice did not develop emphysema, showing protection toward oxidative damage to DNA and apoptosis as revealed by a trivial 8-hydroxyguanosine staining and faint TUNEL and caspase-3 positivity on alveolar epithelial cells. Unexpectedly, CS exposure in p66Shc–/– mice resulted in respiratory bronchiolitis with fibrosis in surrounded alveoli. Respiratory bronchiolitis was characterized by peribronchiolar infiltrates of lymphocytes and histiocytes, accumulation of ageing pigmented macrophages within and around bronchioles, and peribronchiolar fibrosis. The blockage of apoptosis interferes with the macrophage “clearance” from alveolar spaces, favouring the accumulation of aging macrophages into alveoli and the progressive accumulation of iron pigment in long-lived senescent cells. The presence of areas of interstitial and alveolar fibrosis in peripheral parenchyma often accompanied the bronchiolar changes. Macrophages from smoking p66Shc–/– mice elaborate M2 cytokines (i.e., IL-4 and IL-13) and enzymes (i.e., chitinase and arginase I), which can promote TGF-beta expression, collagen deposition, and fibrosis in the surrounding areas. We demonstrate here that resistance to oxidative stress and p53-dependent apoptosis can modify tissue responses to CS caused by chronic inflammation without influencing early inflammatory response to CS exposure.Keywords
This publication has 54 references indexed in Scilit:
- Macrophage Heterogeneity in Respiratory DiseasesMediators of Inflammation, 2013
- Senescence in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2012
- FOXO3 Deficiency Leads to Increased Susceptibility to Cigarette Smoke-Induced Inflammation, Airspace Enlargement, and Chronic Obstructive Pulmonary DiseaseThe Journal of Immunology, 2011
- Oxidative DNA damage in lung tissue from patients with COPD is clustered in functionally significant sequencesInternational Journal of Chronic Obstructive Pulmonary Disease, 2011
- Absence of Proteinase-Activated Receptor-1 Signaling in Mice Confers Protection from fMLP-Induced Goblet Cell MetaplasiaAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramideAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Genetic Deletion of the p66 Shc Adaptor Protein Protects From Angiotensin II–Induced Myocardial DamageHypertension, 2005
- Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial ApoptosisCell, 2005
- p66SHC: The apoptotic side of Shc proteinsApoptosis, 2005
- p66 ShcA Modulates Tissue Response to Hindlimb IschemiaCirculation, 2004